Haifeng Wu

5.5k total citations · 1 hit paper
86 papers, 3.6k citations indexed

About

Haifeng Wu is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Haifeng Wu has authored 86 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 22 papers in Hematology and 20 papers in Nephrology. Recurrent topics in Haifeng Wu's work include Complement system in diseases (33 papers), Renal Diseases and Glomerulopathies (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Haifeng Wu is often cited by papers focused on Complement system in diseases (33 papers), Renal Diseases and Glomerulopathies (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Haifeng Wu collaborates with scholars based in United States, China and United Kingdom. Haifeng Wu's co-authors include Spero R. Cataland, Ming Jin, Brad H. Rovin, Lee A. Hebert, Tibor Nádasdy, Gyongyi Nadasdy, Shangbin Yang, Marie Scully, Flora Peyvandi and Chengjiang Gao and has published in prestigious journals such as New England Journal of Medicine, Blood and Nature Immunology.

In The Last Decade

Haifeng Wu

83 papers receiving 3.5k citations

Hit Papers

Caplacizumab for Acquired Thrombotic Thrombocytopenic Pur... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haifeng Wu United States 32 2.1k 1.1k 963 778 633 86 3.6k
Zoltán Lászik United States 27 1.0k 0.5× 472 0.4× 864 0.9× 998 1.3× 265 0.4× 87 3.9k
Deborah J. Stearns-Kurosawa United States 27 804 0.4× 176 0.2× 1.5k 1.5× 649 0.8× 422 0.7× 39 3.4k
Patricia C. Liaw Canada 35 1.7k 0.8× 157 0.1× 1.1k 1.2× 1.1k 1.4× 282 0.4× 95 4.5k
Ulf Panzer Germany 38 2.4k 1.1× 1.9k 1.8× 381 0.4× 1.0k 1.3× 199 0.3× 81 5.2k
C. Arnold Spek Netherlands 41 946 0.4× 137 0.1× 1.5k 1.6× 1.7k 2.2× 547 0.9× 165 5.1k
Geir E. Tjønnfjord Norway 37 1.4k 0.7× 139 0.1× 2.9k 3.0× 722 0.9× 1.6k 2.5× 217 5.7k
Volker Vielhauer Germany 36 1.9k 0.9× 1.6k 1.5× 344 0.4× 913 1.2× 160 0.3× 67 4.4k
Thomas J. Dengler Germany 35 1.1k 0.5× 372 0.3× 198 0.2× 1.7k 2.2× 212 0.3× 109 4.2k
Wilma Barcellini Italy 42 1.7k 0.8× 272 0.3× 3.1k 3.2× 582 0.7× 1.6k 2.5× 320 6.2k
Giuseppe A. Andres United States 42 1.3k 0.6× 1.7k 1.6× 336 0.3× 886 1.1× 272 0.4× 138 4.7k

Countries citing papers authored by Haifeng Wu

Since Specialization
Citations

This map shows the geographic impact of Haifeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Wu more than expected).

Fields of papers citing papers by Haifeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Wu. The network helps show where Haifeng Wu may publish in the future.

Co-authorship network of co-authors of Haifeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Wu. A scholar is included among the top collaborators of Haifeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Wu. Haifeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Haifeng, et al.. (2024). Risk Factors of Lower Extremity Deep Vein Thrombosis After Artificial Femoral Head Replacement for Elderly Femoral Neck Fractures and a Nomogram Model Construction.. PubMed. 30(8). 325–331.
3.
Gai, Xiaoyan, Wenli Cao, Lin Zeng, et al.. (2023). Risk factors and biomarkers for post-tuberculosis lung damage in a Chinese cohort of male smokers and non-smokers: protocol for a prospective observational study. BMJ Open. 13(10). e065990–e065990. 2 indexed citations
4.
Chen, Jian, et al.. (2017). Increased complement activation during platelet storage. Transfusion. 57(9). 2182–2188. 20 indexed citations
5.
Liu, Bingyu, Meng Zhang, Honghai Zhang, et al.. (2016). The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nature Immunology. 18(2). 214–224. 255 indexed citations
6.
Lu, Ruinan, Shijie Yang, Haifeng Wu, & X. Long Zheng. (2015). Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease. Journal of Thrombosis and Haemostasis. 13(6). 1064–1072. 18 indexed citations
7.
An, Li‐Xin, et al.. (2014). Electro-Acupuncture Decreases Postoperative Pain and Improves Recovery in Patients Undergoing a Supratentorial Craniotomy. The American Journal of Chinese Medicine. 42(5). 1099–1109. 60 indexed citations
8.
Cataland, Spero R. & Haifeng Wu. (2014). Diagnosis and management of complement mediated thrombotic microangiopathies. Blood Reviews. 28(2). 67–74. 35 indexed citations
9.
Lotta, Luca A., Haifeng Wu, Khaled M. Musallam, & Flora Peyvandi. (2013). The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura. Blood Reviews. 27(2). 71–76. 12 indexed citations
10.
Xu, Wei, Haifeng Wu, Shao-Gang Ma, et al.. (2013). Correlation between Peripheral White Blood Cell Counts and Hyperglycemic Emergencies. International Journal of Medical Sciences. 10(6). 758–765. 45 indexed citations
11.
Ware, Kyle, Anjali A. Satoskar, Tibor Nádasdy, et al.. (2011). Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation. Journal of the American Society of Nephrology. 22(10). 1856–1862. 75 indexed citations
12.
Jin, Ming, T. Charles Casper, Spero R. Cataland, et al.. (2008). Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse. British Journal of Haematology. 141(5). 651–658. 98 indexed citations
13.
Yang, Shangbin, Lihui Xu, & Haifeng Wu. (2008). Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry. Blood. 112(11). 4053–4053. 2 indexed citations
14.
Shang, Dezhi, Haifeng Wu, Spero R. Cataland, et al.. (2008). Multiple Non-Linear Epitopes of ADAMTS13 Were Targeted by Anti- ADAMTS13 IgG in Patients with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura. Blood. 112(11). 276–276. 1 indexed citations
15.
Varker, Kimberly A., Cheryl Kefauver, Amy Lehman, et al.. (2007). A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma. Annals of Surgical Oncology. 14(8). 2367–2376. 118 indexed citations
16.
Wu, Haifeng, Xiaofeng Zhang, Ye Deng, Li Pan, & Li‐Sheng Ding. (2007). [Studies on chemical constituents from bark of Biebersteinia heterostemon].. PubMed. 32(20). 2141–3. 2 indexed citations
17.
Jin, Ming, Spero R. Cataland, M.G. Bissell, & Haifeng Wu. (2006). A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time‐of‐flight (SELDI‐TOF)‐mass spectrometry. Journal of Thrombosis and Haemostasis. 4(2). 333–338. 56 indexed citations
18.
Cataland, Spero R. & Haifeng Wu. (2005). Immunotherapy for thrombotic thrombocytopenic purpura. Current Opinion in Hematology. 12(5). 359–363. 19 indexed citations
19.
Jin, Ming, et al.. (2005). Distinct proteome features of plasma microparticles. PROTEOMICS. 5(7). 1940–1952. 84 indexed citations
20.
Cataland, Spero R., Ming Jin, Amy K. Ferketich, et al.. (2005). Cyclosporine and Plasma Exchange Is Superior to Corticosteroids and Plasma Exchange as Initial Therapy of TTP.. Blood. 106(11). 1235–1235. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026